Private equity

The Nexus of secondaries 2026

We’ll hear the latest on the market’s innovation, capitalisation, tailwinds and headwinds at PEI Group’s Nexus 2026.

CVC buys into M&G’s $1bn-plus managed fund deal

The deal sees a portfolio of private equity interests move into a new vehicle run by M&G.

Adams Street and Lexington lead Vitruvian’s $1bn+ fundraise

The vehicle, named Andantino AV, has some CV components and houses Vitruvian’s ownership in four assets, Secondaries Investor understands.

Florida SBA explores multibillion-dollar portfolio sale

The pension has been actively pursuing opportunities in the secondaries market over the past few years.

CVC emerges as lead in Cerberus’s large CV for SubCom

The deal marks the latest $1bn-plus CV the Luxembourg-headquartered firm has been involved in over the last several months.

GPs should listen to the LP-led secondaries market signal

Holding on to laggard assets may conflict with the core objective of PE: maximising time-weighted returns for LPs, writes Adam Spence, of Partners Capital.

Hayfin anchors €155m Spanish healthcare CV

Spanish manager Alantra has closed a continuation vehicle for its portfolio company Health in Code, with 25% of the capital earmarked for follow on investment.

StepStone eyes first closes for flagship, debut GP-led fund by H1 2026 – updated

StepStone’s live secondaries fundraising also includes vehicles dedicated to infra and VC, executives said on the firm’s recent earnings call.

KKR sees $100bn potential in Arctos acquisition

‘We really like the idea of building a secondary platform with a blank sheet of paper,’ KKR CFO Rob Lewin said on the firm’s Q4 2025 earnings call.

The return of the zombie fund

Pressures in private equity continued in 2025, with fundraising dipping by 17% year on year in 2025.